World news about “Pharmaceutical companies” published by euronews.
EU fines drugmakers over ‘pay-for-delay’ Nine drugmakers have been fined by EU competition regulators for blocking a cheaper anti-depressant medicine from coming to the market. Danish firm Lundbeck… 19/06/2013
Interpol global drug bust You risk your life if you buy fake drugs online. The International Criminal Police Organisation Interpol has just completed a week-long global bust… 04/10/2012
Milking plants A French company is growing fast as it exploits a technology to ‘milk’ precious products from plants. “We produce molecules from plants that otherwise would… 05/07/2012
AstraZeneca boss quits as sales fall AstraZeneca’s Chief Executive David Brennan is to step down at the start of June. Brennan’s abrupt exit after six years running Britain’s second-biggest… 26/04/2012
Innate inks cancer drug tie-up with BMS Shares in the small French biotech firm Innate shot up 70 percent on Thursday after it reached a deal with Bristol-Myers Squibb over a new anti-cancer… 07/07/2011
Johnson & Johnson connected to Synthes The US healthcare group Johnson & Johnson is to buy Swiss medical devices maker Synthes for the equivalent of 14.8 billion euros. It is Johnson & Johnson’s… 27/04/2011
Rhodia purchase to give Solvay emerging markets boost Belgian chemicals group Solvay is set to take over France’s Rhodia with a 3.4 billion euros cash bid. Solvay is looking to improve sales in emerging markets… 04/04/2011
EU practical, legal steps against fake drugs The fight against counterfeit medicines has a new European directive on its side, approved by the European Parliament and expected to win the green light soon… 16/02/2011
New flu jab gets under the skin Anywhere from 40,000 to 220,000 people die in Europe from flu each year. Although vaccines against seasonal flu have been around for some time, pharmaceutical… 14/12/2010
Countering counterfeit medicines Police and medicine agencies are going on the offensive in a bid to stop fake drugs flooding into Europe. The authorities are preparing to implement new… 05/11/2010
Protesters say cheap drugs threatened by India court battleThe Indian headquarters of Swiss drugmaker Novartis has been surrounded by protesters demanding the right to cheap drugs. Several people living with … 21/12/2012
Police investigate killer cough mixture in PakistanAt least 16 people have died in Pakistan’s second city Lahore after drinking suspect cough-syrup. A medicine factory and several pharmacies have been… 28/11/2012
Thalidomide’s makers issue first ever apologyThe German firm which made thalidomide has issued an apology for the first time to victims of the drug. In the 1950s, thousands of children were born with… 01/09/2012
French company to go on trial over Mediator drug scandalThe French pharmaceutical company Servier was due to go on trial on Monday over a diabetes drug, which is said to have caused up to 2000 deaths. According… 14/05/2012
Sweetened offer wins Genzyme for SanofiFrench drugmaker Sanofi-Aventis has agreed to buy US biotech group Genzyme with a improved cash offer the equivalent of almost 14.9 billion euros. It will… 16/02/2011
Sanofi: Genzyme takeover talks progressingSanofi-Aventis has said it is making progress on the purchase of US biotech firm Genzyme. At the same time the French drugmaker said its earning this year… 09/02/2011
Roche downbeat on 2011 profitThere has been a cautious outlook for earnings this year from Swiss drugmaker Roche after growth of its top-seller, the cancer treatment Avastin, slowed… 02/02/2011
Sanofi extends Genzyme bid againFrench drugmaker Sanofi-Aventis has extended its offer for US biotech firm Genzyme for a second time, as they continue talks on a deal. The 13.6 billion… 24/01/2011
US setback for AstraZenecaAstraZeneca has suffered a big setback as its new heart medicine – Brilinta – has failed to win immediate approval from US regulators. That means a delay of… 17/12/2010
Novartis Alcon deal completedNovartis has completed its long-awaited buyout of the remainder of the US eyecare group Alcon that it did not already own. The Swiss drugmaker is paying the… 15/12/2010
Roche to cut costs, jobsSwiss drugmaker Roche has revealed plans to slash costs including cutting jobs. It intends to reduce its outgoings by the equivalent of 1.8 billion euros a… 17/11/2010
Sanofi gets competition OK for GenzymeFrance’s Sanofi Aventis has moved a step closer to taking over American biotech firm Genzyme as US competition regulators have given it the green light… 20/10/2010
Pfizer buying King PharmaThe world’s biggest drugmaker, Pfizer, continues to expand. It has agreed to buy King Pharmaceuticals for the equivalent of 2.6 billion euros in cash… 12/10/2010
Sanofi goes hostile with Genzyme bidAs expected, Sanofi-Aventis has launched a hostile takeover bid for US biotechnology firm Genzyme. The French drugmaker is taking its 13.5 billion euro… 04/10/2010
Glaxo forecasts cut on Avandia banAnalysts have cut their earnings forecasts for GlaxoSmithKline after the European Medicines Agency banned the sale of its once best-selling diabetes drug… 24/09/2010
FDA wants more time on heart drugAnglo-Swedish drugs firm AstraZeneca has been hit by the news that US regulators want to take another three months before deciding whether to approve its new… 15/09/2010
Sanofi ups its bid to buy GenzymeFrench pharmaceuticals group Sanofi-Aventis has made a new bid to buy US biotech company Genzyme. Sanofi is offering 71 dollars a share, or just over 55… 09/09/2010
Roche to trim costsRoche is reviewing its business in order to cut costs. The Swiss drugmaker said that is in response to recent setbacks in the development of key drugs and… 03/09/2010
Genzyme’s boss wants higher priceGenzyme’s Chief Executive Henri Termeer has said he is willing to sell his company, but not at the price that French drugmaker Sanofi-Aventis is offering… 01/09/2010
Genzyme rejects Sanofi-Aventis bidUS biotech firm Genzyme has rejected Sanofi-Aventis’ 14.5 billion euro offer as too low. That came after Sanofi Chief Executive Chris Viehbacher hinting he… 30/08/2010
Scientists get encouraging results on new cancer drugScientists at London’s King College say they’ve carried out encouraging tests on a new treatment that promises to shrink breast cancer tumours and help… 15/07/2010
Flu vaccines boost Novartis salesSwiss drugmaker Novartis enjoyed first quarter sales that were up 18 percent and said it is confident of meeting its targets for this year. But analysts… 20/04/2010
Roche sales better than forecastSwiss drugmaker Roche’s sales in the first-three months of the year were better than expected – up by six percent on the same period last year at 8.5 billion… 15/04/2010
Novartis eyes AlconSwiss drugmaker Novartis is moving to take full control of US based Alcon, the world’s biggest eye care firm. The purchase is to help Novartis diversify… 04/01/2010
Merck and Schering-Plough begin joint operationsUS pharmaceuticals giants Merck and Schering Plough have begun their first day of combined operations following the completion of their merger. The new… 04/11/2009
Swine flu gives Sanofi a shot in the armFrench drugmaker Sanofi-Aventis has swine flu to thank for an improved outlook for 2009. The group said it expected H1N1 vaccines to add around 337 million… 30/10/2009
Bayer’s operating earnings beat forecastsGermany’s largest drugmaker Bayer has beaten forecasts with their operating earnings. Profits were helped by a continued recovery of their plastics… 27/10/2009
Pfizer completes Wyeth takeoverPfizer has completed its takeover of rival Wyeth making the world’s largest drugmaker even bigger. US and Canadian competition regulators cleared the deal… 16/10/2009
Tamiflu boosts Roche’s salesSwiss pharmaceutical company Roche enjoyed an almost 10 percent rise in third-quarter sales thanks to better than expected demand for Tamiflu which is being… 15/10/2009
Belgium’s Solvay sells drugs divisionBelgium pharmaceutical, chemicals and plastics giant Solvay has announced it is to sell its drugs arm to US partner Abbott Laboratories. Solvay says the… 28/09/2009
Drugmaker Pfizer slapped with record fine for fraudThe world’s biggest drugmaker Pfizer has agreed to pay a record fine of over 1.6 billion euros in one of the largest-ever healthcare fraud cases. The … 03/09/2009
Novartis raises sales forecastEncouraging news from drugmaker Novartis which has raised its forecast for sales this year, betting on income from cancer and heart medicines. The Swiss… 16/07/2009
Drug firms warned over genericsAn investigation into pharmaceutical companies conducted by the European Commission has followed up a preliminary report made public last November warning… 08/07/2009
Genentech accepts Roche offerSwiss drugmaker Roche has reached a deal with Genentech to acquire all of the shares in the US biotech group that it does not already own. Over the last… 12/03/2009
Merck to merge with Schering-PloughUS drug maker Merck is to buy Schering-Plough in the second huge takeover in the sector in weeks following Pfizer’s recent purchase of Wyeth. Merck will… 09/03/2009
